Expanding the evidence for rivaroxaban in Atrial Fibrillation (AF) patients with comorbidites including Heart Failure (HF): from Randomized Controlled Trials (RCT) to Real World Evidence (RWE).
30 April 2017 (12:50 - 13:05)
Organised by:
About the speaker
London (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Professor K. Fox (Edinburgh, GB)
Professor B. Greenberg (La Jolla, US)
Doctor R. Mentz (Durham, US)
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
30 April 2017
12:50 CET
You may be interested in
Congress Session
Congress Presentation
